Release
📈 Stocks
NeuroSense to Present PARADIGM Clinical Data at NEALS 2026 Conference
(just now)
NeuroSense Therapeutics plans to showcase PARADIGM program results at NEALS 2026, detailing how clinical and biomarker evidence is shaping the Phase 3…